Clinical trial

The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

NCT01137799

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention JNJ-39393406 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention JNJ-39393406 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-08-01

PhasePHASE1

Conditions

Schizophreniaverified · MONDO: schizophrenia

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Cognition Disordersunresolved

Interventions

JNJ-39393406DRUG

placeboDRUG

JNJ-39393406DRUG

Sponsors & collaborators

Janssen Pharmaceutica N.V., Belgiumlead sponsor

Mapped research locations

BerlinGermany1 MünchenGermany1 ErlangenGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01137799 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.